No incurable illnesses

Dr. Weeks Comment:  In the 1400s, before he was murdered by his medical board, the then greatest medical doctor in western civilization, a great mentor of mine, Paracelsus (whose entire name is Philippus Aureolus Theophrastus Bombastus von Hohenheim) made the following at once provocative and inspiring statement: “There are no incurable illnesses. There are just incurable people.”  That statement has helped me help patients attain miracles in the past 35 years.  A more modern and also great doctor  Bernie Siegel MD,  the Yale cancer surgeon who quit cutting out patients’ cancers once he understood that there is no “it” to cut out but rather that cancer is a process and that emotional dis-ease drives cancer talked about the “exceptional cancer patient”. He reasoned, if 9 out of 10 people die of a certain cancer, why aren’t we studying the 10th person – the survivor???  Both these medical mavericks are asking questions relevant to anyone suffering today from astonishingly arrogant or ignorant edicts uttered by their well-intentioned but suboptimal doctor when saying “There is no hope” or “Your illness is incurable.”   As I stated publicly at my Truth about Cancer (TTAC)  lecture STRIKE THE ROOT, when the doctor (frocked as she or he is in the symbolic awe-inspiring white coat) says: “You have 6 months to live.” that is actually assault with a deadly weapon… image the hit sustained by the immune system when hit by that edict! It should be an illegal act!!!   Certainly intelligent patients see it for what it is – a statement from a doctor simply declaring not the actual truth, but rather the degree to which their knowledge and experience is limited. Better by far would be a qualified statement like: “In my experience, people who generally meet your criteria typically have no more than 6 months to live because I have no helpful suggestions but you are an individual and all illness and recovery depend to a great degree upon the individual so I wish you well and am willing to support you going forward in any protocols which you decide to follow.”  But most doctors haven’t the perspective to utter such life-sustaining words, so they assault trusting patients with a deadly weapon – words which are worse than sticks and stones.

Today, I spoke with a gentleman whose neurologist had told him that there was “no hope“.  Again, I was so saddened that this person actually believed his limited neurologist!  I asked if his neurologist knew about nerve growth factor. The patient replied that it was not discussed.   So in frustration, I am publicly sharing just the tip of the iceberg about nerve regeneration.  Here below are many articles on nerve growth factor -first isolated by Nobel Laureates Rita Levi-Montalcini and Stanley Cohen in 1956. That should create hope in patients suffering from neurological problems.  Also, we know that unadulterated omega 6 fatty acids can “kick out” adulterated, rancid fatty acids thus remodeling and rejuvenating injured nerve tissue.  People who were bedridden with MS for years walk again.  We know that mold toxicity can mimic ALS  and create the inability to walk and we know that anti-inflammatory agents can clear up all neurological pathology including dementia. We know that progesterone deficiency can create neurological problems and that patients with nerve damage benefit from bio-identical progesterone.  Many people benefit from transdermal progesterone in cosmetic products such as Calm Cream.

So here is some recent info on Nerve Growth Factor to remind people that never CAN and do regenerate!


Nerve growth factor administration protects against experimental diabetic sensory neuropathy

SC Apfel, JC Arezzo, M Brownlee, H Federoff… – Brain research, 1994 – Elsevier
Small fiber sensory neuropathy is one of the most common complications of diabetes
mellitus. Currently there is no adequate therapy to prevent this often debilitating problem.
Nerve growth factor (NGF) is a protein that promotes the survival and integrity of a large …

Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy

R Hellweg, HD Hartung – Journal of neuroscience research, 1990 – Wiley Online Library
Sympathetic and neural‐crest derived sensory neurons consisting of unmyelinated and
small myelinated fibers are known to be affected at an early stage in diabetes mellitus (DM).
Since these peripheral neurons need nerve growth factor (NGF) for their development and …

Nerve growth factor prevents toxic neuropathy in mice

SC Apfel, RB Lipton, JC Arezzo… – Annals of Neurology …, 1991 – Wiley Online Library
Taxol is a promising new antitumor drug with therapeutic use that is limited by a toxic
sensory neuropathy. Taxol is also cytotoxic to dorsal root ganglion neurons in vitro, but this
effect is prevented by cotreatment with the trophic protein, nerve growth factor. We sought to …

The role of endogenous nerve growth factor in human diabetic neuropathy

P Anand, G Terenghi, G Warner, P Kopelman… – Nature medicine, 1996 –
Nerve growth factor (NCF) is trophic to sensory and sympathetic fibers 1–3. In animal
models, NGF is depleted in diabetic nerves 4 and NGF deprivation produces hypoalgesia 5.
Exogenous NGF can reverse some of the pathological changes in diabetic nerves 1, 6 and …

Nerve growth factor prevents experimental cisplatin neuropathy

SC Apfel, JC Arezzo, L Lipson… – Annals of Neurology …, 1992 – Wiley Online Library
Cisplatin is a widely used antitumor agent, the dose‐limiting toxicity of which is
predominantly large‐fiber sensory neuropathy. Prevention of such a neuropathy would
extend the usefulness of this agent, allowing higher doses and longer periods of treatment …

A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection

JC McArthur, C Yiannoutsos, DM Simpson… – Neurology, 2000 – AAN Enterprises
Objective: To evaluate the safety and efficacy of recombinant human nerve growth factor 
(rhNGF) in HIV-associated sensory neuropathy (SN) within a multicenter, placebo-
controlled, randomized trial (ACTG 291). Background: SN affects 30% of individuals with …

Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?

SC Apfel – International review of neurobiology, 2002 – Elsevier
Since their discovery in the 1950s, neurotrophic factors have raised expectations that their
clinical application to neurodegenerative diseases might provide an effective therapy for
what are now untreatable conditions. Nerve growth factor (NGF) was the first neurotrophic …

 Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial

SC Apfel, S Schwartz, BT Adornato, R Freeman… – Jama, 2000 –
… that plays a major role in the development and maintenance of the peripheral nervous system …
attributable to diabetes mellitus as determined by a neurologist, and abnormal results of nerve
conduction studies in 1 or more attributes of 2 or more nerves studied (≥99th …




Leave a Comment

Your email address will not be published. Required fields are marked *